Table 1 Demographic characteristics.

From: High diagnosis rate for nonimmune hydrops fetalis with prenatal clinical exome from the Hydrops-Yielding Diagnostic Results of Prenatal Sequencing (HYDROPS) Study

Family ID/state

Maternal age/ethnicity

Paternal age/ethnicity

GA at diagnosis

Pregnancy outcome

Sample source

Prestudy genetic findings

NIHF1-001 KS

27 years/Caucasian

27 years/Hispanic

15 weeks 3 days

IUFD at 23 weeks 0 days

Fetal cystic hygroma fluid

Microarray: normal male

NIHF1-002 TX

30 years/Asian

31 years/Asian

31 weeks 6 days

Live born

Cord blood

Microarray: 35 kb VUS loss of 17q24

NIHF1-003 MD

24 years/Black, African American

23 years/Black, African American

19 weeks 0 days

Live born

Amniotic fluid

Microarray: normal male

NIHF1-004 VA

30 years/Caucasian

42 years/Caucasian

19 weeks 6 days

IUFD at 21 weeks 5 days

Amniotic fluid

Microarray: normal male

NIHF1-005 OH

19 years/Caucasian

21 years/Caucasian

20 weeks 4 days

Live born

Amniotic fluid

Microarray: normal male

Noonan panel: negative

NIHF1-006 OH

29 years/Caucasian

32 years/Caucasian

23 weeks 3 days

Live born, death HOL 1

Amniotic fluid

Microarray: normal male

NIHF1-007 ND

30 years/Caucasian

32 years/Caucasian

29 weeks 3 days

Live born, death HOL 35

Amniotic fluid

Microarray: normal female

NIHF1-008 AZ

30 years/Caucasian

39 years/Caucasian

23 weeks 0 days

Live born, death HOL 1

Amniotic fluid

Microarray: normal female

NIHF1-009 MD

33 years/South Asian

35 years/South Asian

24 weeks 0 days

Termination at 26 weeks 2 days

Amniotic fluid

Microarray: normal male

Noonan panel: negative

NIHF1-010 PA

30 years/Caucasian

31 years/Caucasian

32 weeks 1 day

Live born, death DOL 2

Amniotic fluid

Microarray: normal female

Noonan panel: negative

NIHF1-011 SC

27 years/Caucasian

31 years/Caucasian

18 weeks 4 days

Live born, death DOL 28

Amniotic fluid

Microarray: normal female

Noonan panel: negative

NIHF1-012 TX

28 years/Hispanic

29 years/Hispanic

20 weeks 3 days

Termination at 21 weeks 3 days

Amniotic fluid

Microarray: normal female

NIHF2-013 NC

31 years/Caucasian

33 years/Caucasian

32 weeks 5 days

IUFD at 32 weeks 5 days

Amniotic fluid

Microarray: 222 kb VUS duplication at 12q13

NIHF2-014 IL

26 years/Caucasian

23 years/Caucasian, Hispanic

17 weeks 1 day

IUFD at 27 weeks 5 days

Products of conception

Microarray: normal male

NIHF2-015 MD

28 years/Caucasian

30 years/Asian

29 weeks 6 days

IUFD at 32 weeks 2 days

Fetal quadriceps

Microarray: normal female

NIHF2-016 IL

31 years/Hispanic

29 years/Caucasian

29 weeks 4 days

IUFD at 30 weeks 2 days

Placental tissue

Microarray: normal male

NIHF1-017 MI

30 years/Caucasian

29 years/Caucasian

19 weeks 2 days

Live born

Amniotic fluid

Microarray: normal male

NIHF1-018 DE

32 years/Caucasian

32 years/Caucasian

19 weeks 5 days

Termination at 20 weeks 5 days

Amniotic fluid

Microarray: normal female

Arthrogryposis panel: negative

NIHF2-019 NJ

37 years/Caucasian

38 years/Caucasian

23 weeks 3 days

IUFD at 24 weeks 3 days

Amniotic fluid

Microarray: normal female

NIHF1-020 OH

35 years/Caucasian

36 years/Caucasian

24 weeks 3 days

Live born, death HOL 1

Amniotic fluid

Microarray: normal male

NIHF2-021 MD

30 years/Hispanic

29 years/Hispanic

19 weeks 5 days

IUFD at 25 weeks 6 days

Amniotic fluid

Microarray: normal male

NIHF1-022 ND

34 years/Caucasian

34 years/Caucasian

25 weeks 2 days

IUFD at 27 weeks 2 days

Amniotic fluid

Microarray: normal female

  1. DOL day of life, GA gestational age, HOL hour of life, IUFD intrauterine fetal demise, NIHF1 DNA obtained during continuing pregnancy, NIHF2 DNA obtained after fetal demise.